2024

1. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

   Diabetes and Metabolism, Vol. 50, Núm. 1

2. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study

   Diabetes Technology and Therapeutics, Vol. 26, Núm. 1, pp. 1-10